April 10, 2013 / 5:46 AM / 5 years ago

Ipsen signs research accord with Japan's Peptidream

PARIS, April 10 (Reuters) - French pharmaceutical group Ipsen has signed a research partnership with Japan’s Peptidream to develop therapeutic peptides for serious diseases in Ipsen’s focus areas of neurology, endocrinology, and oncology.

No financial terms were disclosed, the groups said in a joint statement on Wednesday, but the accord includes optional licensing to discover and commercialise discoveries from the partnership. (Reporting by Leila Abboud; Editing by Catherine Bremer)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below